US Drug Recall Register
Class II · Moderate risk Completed Initiated Apr 5, 2022 (4 years ago)

Trulicity

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

What was recalled

Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80

Recalling firm
Cardinal Health Inc.
NDC code
00002-1434-80
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0883-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Dulaglutide recalls

See all
Class II · Moderate risk Completed

Trulicity

Reason TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Cardinal Health Inc. NDC 0002-1433-80 D-0884-2022
Class II · Moderate risk Terminated

Trulicity

Reason Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

Eli Lilly & Company NDC 0002-1433-80 D-0773-2021